JANX
#2482
Janux Therapeutics, Inc. - Common Stock
16.1 4 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.59%
Monthly Change
+17.90%
6 month change
+14.31%
Year Change
-39.44%
Previous Close
16.4 0
Open
16.1 4
Low
16.1 4
High
16.1 4
Volume
64
Financials
- Market Capitalization 984.29 M
- Employee 108
- Founded 2017
- CEO N/A
- Website www.januxrx.com
- Headquarter Delaware, United States
- FIGI BBG00ZHSKH11
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-7.54
Price to sales ratio
85.51
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2457 |  SANA Sana Biotechnology, Inc. - Common Stock | 3.64 USD | -5.45% | -8.54% | +32.36% | -13.74% | 1.01 B USD | ||
| 2476 |  AVTX Avalo Therapeutics, Inc. - Common Stock | 18.91 USD | -1.56% | -7.30% | +25.98% | +285.13% | 994.01 M USD | ||
| 2484 |  ANRO Alto Neuroscience, Inc. Common Stock | 28.03 USD | +5.93% | +5.34% | +30.25% | +930.51% | 983.68 M USD | ||
| 2486 |  VOR Vor Biopharma Inc. - Common Stock | 18.03 USD | -5.80% | -10.74% | +22.24% | +37.63% | 976.97 M USD |
Frequently asked questions about Janux Therapeutics, Inc. - Common Stock
What is the Janux Therapeutics, Inc. - Common Stock stock price today?
The current price of Janux Therapeutics, Inc. - Common Stock (JANX) is 16.14. Over the past 24 hours, the stock has changed by -1.59%. Follow the JANX chart for real-time price dynamics.
What is the stock ticker of Janux Therapeutics, Inc. - Common Stock?
Janux Therapeutics, Inc. - Common Stock trades under the ticker JANX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Janux Therapeutics, Inc. - Common Stock stock going up?
JANX has changed by +3.00% over the last week, +17.90% over the last month, and -39.44% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Janux Therapeutics, Inc. - Common Stock net income for the last quarter?
Janux Therapeutics, Inc. - Common Stock reported net income of -24.36 M for the last quarter. The previous quarter showed -31.95 M, which means net income changed by +23.74%.
How many employees does Janux Therapeutics, Inc. - Common Stock have?
As of the latest available data, Janux Therapeutics, Inc. - Common Stock has 108 employees. Workforce size can provide additional context about the company's scale and operations.
What is Janux Therapeutics, Inc. - Common Stock EBITDA?
Janux Therapeutics, Inc. - Common Stock EBITDA is -47.5 M, and its EBITDA margin is -1 272.46%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Janux Therapeutics, Inc. - Common Stock stock?
You can buy Janux Therapeutics, Inc. - Common Stock (JANX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Janux Therapeutics, Inc. - Common Stock stock?
Investing in Janux Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the JANX chart and related analysis on metatrader.com as part of your research.